Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries
Identifieur interne : 002007 ( Istex/Corpus ); précédent : 002006; suivant : 002008Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries
Auteurs : Jing Sun ; Alexandra Crispim Boing ; Marysabel Pt Silveira ; Andréa D. Bertoldi ; Liliya E. Ziganshina ; Veronica N. Khaziakhmetova ; Rashida M. Khamidulina ; Maulik R. Chokshi ; Shelley Mcgee ; Fatima SulemanSource :
- Journal of Evidence‐Based Medicine [ 1756-5383 ] ; 2014-02.
Abstract
This article illustrates how the BRICS countries have been building their focused leadership, making important high level commitment and national policy changes, and improving their health systems, in addressing the HIV/AIDS epidemics in respective settings. Specific aspects are focused on efforts of creating public provisions to secure universal access to ARVs from the aspects of active responsive system and national program, health system strengthening, fostering local production of ARVs, supply chain management, and information system strengthening. Challenges in each BRICS country are analyzed respectively. The most important contributors to the success of response to HIV/AIDS include: creating legal basis for healthcare as a fundamental human right; political commitment to necessary funding for universal access and concrete actions to secure equal quality care; comprehensive system to secure demands that all people in need are capable of accessing prevention, treatment and care; active community involvement; decentralization of the management system considering the local settings; integration of treatment and prevention; taking horizontal approach to strengthen health systems; fully use of the TRIPS flexibility; and regular monitoring and evaluation to serve evidence based decision making.
Url:
DOI: 10.1111/jebm.12081
Links to Exploration step
ISTEX:4019A840609BB93ED0DBEA2B4A948A87ABABC78BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries</title><author><name sortKey="Sun, Jing" sort="Sun, Jing" uniqKey="Sun J" first="Jing" last="Sun">Jing Sun</name><affiliation><mods:affiliation>National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance, Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, China</mods:affiliation></affiliation><affiliation><mods:affiliation>Jing Sun, National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance Country Leader; Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, 38 Xueyuan Road, Haidian District, Beijing 100191, China. Tel: +86‐10‐62026607; Fax: +86‐10‐82801614; :</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: sunjingx@yahoo.com</mods:affiliation></affiliation></author><author><name sortKey="Boing, Alexandra Crispim" sort="Boing, Alexandra Crispim" uniqKey="Boing A" first="Alexandra Crispim" last="Boing">Alexandra Crispim Boing</name><affiliation><mods:affiliation>Department of Public Health, Federal University of Santa Catarina, Brazil</mods:affiliation></affiliation></author><author><name sortKey="Silveira, Marysabel Pt" sort="Silveira, Marysabel Pt" uniqKey="Silveira M" first="Marysabel Pt" last="Silveira">Marysabel Pt Silveira</name><affiliation><mods:affiliation>Instituto de Biologia, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pelotas, Brazil</mods:affiliation></affiliation></author><author><name sortKey="Bertoldi, Andrea D" sort="Bertoldi, Andrea D" uniqKey="Bertoldi A" first="Andréa D" last="Bertoldi">Andréa D. Bertoldi</name><affiliation><mods:affiliation>Programa de Pós‐graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, RS, Brazil</mods:affiliation></affiliation></author><author><name sortKey="Ziganshina, Liliya E" sort="Ziganshina, Liliya E" uniqKey="Ziganshina L" first="Liliya E" last="Ziganshina">Liliya E. Ziganshina</name><affiliation><mods:affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</mods:affiliation></affiliation></author><author><name sortKey="Khaziakhmetova, Veronica N" sort="Khaziakhmetova, Veronica N" uniqKey="Khaziakhmetova V" first="Veronica N" last="Khaziakhmetova">Veronica N. Khaziakhmetova</name><affiliation><mods:affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</mods:affiliation></affiliation></author><author><name sortKey="Khamidulina, Rashida M" sort="Khamidulina, Rashida M" uniqKey="Khamidulina R" first="Rashida M" last="Khamidulina">Rashida M. Khamidulina</name><affiliation><mods:affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</mods:affiliation></affiliation></author><author><name sortKey="Chokshi, Maulik R" sort="Chokshi, Maulik R" uniqKey="Chokshi M" first="Maulik R" last="Chokshi">Maulik R. Chokshi</name><affiliation><mods:affiliation>Public Health Foundation, BRICS Medicines Alliance, India</mods:affiliation></affiliation></author><author><name sortKey="Mcgee, Shelley" sort="Mcgee, Shelley" uniqKey="Mcgee S" first="Shelley" last="Mcgee">Shelley Mcgee</name><affiliation><mods:affiliation>Healthcare Policy Analyst, Market Access, SANOFI, BRICS Medicines Alliance, South Africa</mods:affiliation></affiliation></author><author><name sortKey="Suleman, Fatima" sort="Suleman, Fatima" uniqKey="Suleman F" first="Fatima" last="Suleman">Fatima Suleman</name><affiliation><mods:affiliation>Discipline of Pharmaceutical Sciences, University of KwaZulu‐Natal, BRICS Medicines Alliance, South Africa</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4019A840609BB93ED0DBEA2B4A948A87ABABC78B</idno><date when="2014" year="2014">2014</date><idno type="doi">10.1111/jebm.12081</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-0BHX1WZW-H/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002007</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002007</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries</title><author><name sortKey="Sun, Jing" sort="Sun, Jing" uniqKey="Sun J" first="Jing" last="Sun">Jing Sun</name><affiliation><mods:affiliation>National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance, Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, China</mods:affiliation></affiliation><affiliation><mods:affiliation>Jing Sun, National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance Country Leader; Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, 38 Xueyuan Road, Haidian District, Beijing 100191, China. Tel: +86‐10‐62026607; Fax: +86‐10‐82801614; :</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: sunjingx@yahoo.com</mods:affiliation></affiliation></author><author><name sortKey="Boing, Alexandra Crispim" sort="Boing, Alexandra Crispim" uniqKey="Boing A" first="Alexandra Crispim" last="Boing">Alexandra Crispim Boing</name><affiliation><mods:affiliation>Department of Public Health, Federal University of Santa Catarina, Brazil</mods:affiliation></affiliation></author><author><name sortKey="Silveira, Marysabel Pt" sort="Silveira, Marysabel Pt" uniqKey="Silveira M" first="Marysabel Pt" last="Silveira">Marysabel Pt Silveira</name><affiliation><mods:affiliation>Instituto de Biologia, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pelotas, Brazil</mods:affiliation></affiliation></author><author><name sortKey="Bertoldi, Andrea D" sort="Bertoldi, Andrea D" uniqKey="Bertoldi A" first="Andréa D" last="Bertoldi">Andréa D. Bertoldi</name><affiliation><mods:affiliation>Programa de Pós‐graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, RS, Brazil</mods:affiliation></affiliation></author><author><name sortKey="Ziganshina, Liliya E" sort="Ziganshina, Liliya E" uniqKey="Ziganshina L" first="Liliya E" last="Ziganshina">Liliya E. Ziganshina</name><affiliation><mods:affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</mods:affiliation></affiliation></author><author><name sortKey="Khaziakhmetova, Veronica N" sort="Khaziakhmetova, Veronica N" uniqKey="Khaziakhmetova V" first="Veronica N" last="Khaziakhmetova">Veronica N. Khaziakhmetova</name><affiliation><mods:affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</mods:affiliation></affiliation></author><author><name sortKey="Khamidulina, Rashida M" sort="Khamidulina, Rashida M" uniqKey="Khamidulina R" first="Rashida M" last="Khamidulina">Rashida M. Khamidulina</name><affiliation><mods:affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</mods:affiliation></affiliation></author><author><name sortKey="Chokshi, Maulik R" sort="Chokshi, Maulik R" uniqKey="Chokshi M" first="Maulik R" last="Chokshi">Maulik R. Chokshi</name><affiliation><mods:affiliation>Public Health Foundation, BRICS Medicines Alliance, India</mods:affiliation></affiliation></author><author><name sortKey="Mcgee, Shelley" sort="Mcgee, Shelley" uniqKey="Mcgee S" first="Shelley" last="Mcgee">Shelley Mcgee</name><affiliation><mods:affiliation>Healthcare Policy Analyst, Market Access, SANOFI, BRICS Medicines Alliance, South Africa</mods:affiliation></affiliation></author><author><name sortKey="Suleman, Fatima" sort="Suleman, Fatima" uniqKey="Suleman F" first="Fatima" last="Suleman">Fatima Suleman</name><affiliation><mods:affiliation>Discipline of Pharmaceutical Sciences, University of KwaZulu‐Natal, BRICS Medicines Alliance, South Africa</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Evidence‐Based Medicine</title><title level="j" type="alt">JOURNAL OF EVIDENCE-BASED MEDICINE</title><idno type="ISSN">1756-5383</idno><idno type="eISSN">1756-5391</idno><imprint><biblScope unit="vol">7</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="2">2</biblScope><biblScope unit="page" to="21">21</biblScope><biblScope unit="page-count">20</biblScope><date type="published" when="2014-02">2014-02</date></imprint><idno type="ISSN">1756-5383</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1756-5383</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">This article illustrates how the BRICS countries have been building their focused leadership, making important high level commitment and national policy changes, and improving their health systems, in addressing the HIV/AIDS epidemics in respective settings. Specific aspects are focused on efforts of creating public provisions to secure universal access to ARVs from the aspects of active responsive system and national program, health system strengthening, fostering local production of ARVs, supply chain management, and information system strengthening. Challenges in each BRICS country are analyzed respectively. The most important contributors to the success of response to HIV/AIDS include: creating legal basis for healthcare as a fundamental human right; political commitment to necessary funding for universal access and concrete actions to secure equal quality care; comprehensive system to secure demands that all people in need are capable of accessing prevention, treatment and care; active community involvement; decentralization of the management system considering the local settings; integration of treatment and prevention; taking horizontal approach to strengthen health systems; fully use of the TRIPS flexibility; and regular monitoring and evaluation to serve evidence based decision making.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>brics</json:string><json:string>arvs</json:string><json:string>universal access</json:string><json:string>brics country</json:string><json:string>generic</json:string><json:string>healthcare</json:string><json:string>sichuan university</json:string><json:string>jebm</json:string><json:string>wiley publishing asia</json:string><json:string>sichuan</json:string><json:string>west china hospital</json:string><json:string>chinese cochrane center</json:string><json:string>cochrane</json:string><json:string>health system</json:string><json:string>russian federation</json:string><json:string>unaids</json:string><json:string>september</json:string><json:string>funding</json:string><json:string>pharmaceutical</json:string><json:string>affordable</json:string><json:string>human right</json:string><json:string>nacp</json:string><json:string>antiretroviral</json:string><json:string>public health</json:string><json:string>viral</json:string><json:string>national response</json:string><json:string>public health system</json:string><json:string>health care</json:string><json:string>provider</json:string><json:string>database</json:string><json:string>local production</json:string><json:string>federal level</json:string><json:string>datum</json:string><json:string>private sector</json:string><json:string>aid response</json:string><json:string>family welfare</json:string><json:string>brics medicine alliance</json:string><json:string>civil society</json:string><json:string>ngo</json:string><json:string>aid epidemic</json:string><json:string>centralized procurement</json:string><json:string>country such</json:string><json:string>brazilian government</json:string><json:string>international community</json:string><json:string>aid center</json:string><json:string>aid treatment</json:string><json:string>national aid program</json:string><json:string>health facility</json:string><json:string>aid patient</json:string><json:string>free arvs</json:string><json:string>health policy</json:string><json:string>health sector</json:string><json:string>viral hepatitis</json:string><json:string>overall health system</json:string><json:string>brazil</json:string><json:string>global</json:string><json:string>financial resource</json:string><json:string>public sector</json:string><json:string>trip flexibility</json:string><json:string>national health</json:string><json:string>pharmaceutical industry</json:string><json:string>issue compulsory license</json:string><json:string>disease control</json:string><json:string>production capacity</json:string><json:string>health service</json:string><json:string>price negotiation</json:string><json:string>national program</json:string><json:string>healthcare system</json:string><json:string>total health expenditure</json:string><json:string>drug user</json:string><json:string>information system</json:string><json:string>important contributor</json:string><json:string>chinese government</json:string><json:string>african government</json:string><json:string>global number</json:string><json:string>brazilian experience</json:string><json:string>political commitment</json:string><json:string>human immunodeficiency virus</json:string><json:string>world health organization</json:string><json:string>family planning commission</json:string><json:string>rural area</json:string><json:string>compulsory licensing</json:string><json:string>government funding</json:string><json:string>federal program</json:string><json:string>concrete action</json:string><json:string>medicine price</json:string><json:string>recent year</json:string><json:string>brazilian</json:string><json:string>national center</json:string><json:string>federal government</json:string><json:string>eligible people</json:string><json:string>prevalence rate</json:string><json:string>national aid control organization</json:string><json:string>absolute number</json:string><json:string>other std</json:string><json:string>aid case</json:string><json:string>state council</json:string><json:string>evaluation system</json:string><json:string>international study</json:string><json:string>unified system</json:string><json:string>highest level</json:string><json:string>brazil brazil</json:string><json:string>development partner</json:string><json:string>national free</json:string><json:string>treatment program</json:string><json:string>basic health insurance program</json:string><json:string>development program</json:string><json:string>global death</json:string><json:string>pregnant woman</json:string><json:string>comprehensive intervention</json:string><json:string>infectious disease</json:string><json:string>domestic production</json:string><json:string>recent time</json:string><json:string>brics country table</json:string><json:string>family health program</json:string><json:string>international significance</json:string><json:string>indian government</json:string><json:string>domestic public spending</json:string><json:string>domestic source</json:string><json:string>initial stage</json:string><json:string>priority area</json:string><json:string>international norm</json:string><json:string>soviet union</json:string><json:string>russian health system</json:string><json:string>payroll contribution</json:string><json:string>state medical benefit package</json:string><json:string>insurance company</json:string><json:string>free medicine</json:string><json:string>public drug production</json:string><json:string>prescription medication</json:string><json:string>intravenous drug user</json:string><json:string>innovative medicine</json:string><json:string>health development</json:string><json:string>major domestic</json:string><json:string>international investment</json:string><json:string>russian pharmaceutical industry</json:string><json:string>primary healthcare center</json:string><json:string>intellectual property right</json:string><json:string>medical doctor</json:string><json:string>vertical program</json:string><json:string>increase access</json:string><json:string>governmental policy</json:string><json:string>report aid case</json:string><json:string>treatment access</json:string><json:string>china center</json:string><json:string>public health facility</json:string><json:string>local government</json:string><json:string>other hand</json:string><json:string>horizontal approach</json:string><json:string>public health sector</json:string><json:string>medical scheme</json:string><json:string>accessing prevention</json:string><json:string>healthcare delivery</json:string><json:string>world trade organization</json:string><json:string>essential medicine</json:string><json:string>pharmaceutical company</json:string><json:string>comprehensive system</json:string><json:string>necessary funding</json:string><json:string>legal basis</json:string><json:string>trip agreement</json:string><json:string>public provision</json:string><json:string>local manufacturer</json:string><json:string>product patent</json:string><json:string>patent protection</json:string><json:string>specific aspect</json:string><json:string>generic manufacturer</json:string><json:string>first line</json:string><json:string>pharmaceutical manufacturer</json:string><json:string>respective setting</json:string><json:string>stock level</json:string><json:string>national policy change</json:string><json:string>harm reduction</json:string><json:string>datum acquisition</json:string><json:string>noncommunicable disease</json:string><json:string>progress report</json:string><json:string>datum collection</json:string><json:string>universidade federal</json:string><json:string>china core group</json:string><json:string>international network</json:string><json:string>closer interaction</json:string><json:string>public laboratory</json:string><json:string>pharmaceutical policy research theme group leader</json:string><json:string>hospital administration</json:string><json:string>brazilian constitution</json:string><json:string>national institute</json:string><json:string>brazilian response</json:string><json:string>national health system</json:string><json:string>global report</json:string><json:string>unaids report</json:string><json:string>global aid epidemic</json:string><json:string>antiretroviral treatment</json:string><json:string>antiretroviral drug</json:string><json:string>building brics</json:string><json:string>cape town</json:string><json:string>medication</json:string><json:string>access</json:string><json:string>wiley</json:string></teeft></keywords><author><json:item><name>Jing Sun</name><affiliations><json:string>National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance, Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, China</json:string><json:string>Jing Sun, National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance Country Leader; Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, 38 Xueyuan Road, Haidian District, Beijing 100191, China. Tel: +86‐10‐62026607; Fax: +86‐10‐82801614; :</json:string><json:string>E-mail: sunjingx@yahoo.com</json:string></affiliations></json:item><json:item><name>Alexandra Crispim Boing</name><affiliations><json:string>Department of Public Health, Federal University of Santa Catarina, Brazil</json:string></affiliations></json:item><json:item><name>Marysabel PT Silveira</name><affiliations><json:string>Instituto de Biologia, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pelotas, Brazil</json:string></affiliations></json:item><json:item><name>Andréa D Bertoldi</name><affiliations><json:string>Programa de Pós‐graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, RS, Brazil</json:string></affiliations></json:item><json:item><name>Liliya E Ziganshina</name><affiliations><json:string>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</json:string></affiliations></json:item><json:item><name>Veronica N Khaziakhmetova</name><affiliations><json:string>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</json:string></affiliations></json:item><json:item><name>Rashida M Khamidulina</name><affiliations><json:string>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</json:string></affiliations></json:item><json:item><name>Maulik R Chokshi</name><affiliations><json:string>Public Health Foundation, BRICS Medicines Alliance, India</json:string></affiliations></json:item><json:item><name>Shelley McGee</name><affiliations><json:string>Healthcare Policy Analyst, Market Access, SANOFI, BRICS Medicines Alliance, South Africa</json:string></affiliations></json:item><json:item><name>Fatima Suleman</name><affiliations><json:string>Discipline of Pharmaceutical Sciences, University of KwaZulu‐Natal, BRICS Medicines Alliance, South Africa</json:string></affiliations></json:item></author><articleId><json:string>JEBM12081</json:string></articleId><arkIstex>ark:/67375/WNG-0BHX1WZW-H</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>This article illustrates how the BRICS countries have been building their focused leadership, making important high level commitment and national policy changes, and improving their health systems, in addressing the HIV/AIDS epidemics in respective settings. Specific aspects are focused on efforts of creating public provisions to secure universal access to ARVs from the aspects of active responsive system and national program, health system strengthening, fostering local production of ARVs, supply chain management, and information system strengthening. Challenges in each BRICS country are analyzed respectively. The most important contributors to the success of response to HIV/AIDS include: creating legal basis for healthcare as a fundamental human right; political commitment to necessary funding for universal access and concrete actions to secure equal quality care; comprehensive system to secure demands that all people in need are capable of accessing prevention, treatment and care; active community involvement; decentralization of the management system considering the local settings; integration of treatment and prevention; taking horizontal approach to strengthen health systems; fully use of the TRIPS flexibility; and regular monitoring and evaluation to serve evidence based decision making.</abstract><qualityIndicators><score>9.172</score><pdfWordCount>13358</pdfWordCount><pdfCharCount>86962</pdfCharCount><pdfVersion>1.6</pdfVersion><pdfPageCount>20</pdfPageCount><pdfPageSize>595.274 x 782.286 pts</pdfPageSize><pdfWordsPerPage>668</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>181</abstractWordCount><abstractCharCount>1315</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries</title><genre><json:string>article</json:string></genre><host><title>Journal of Evidence‐Based Medicine</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1756-5391</json:string></doi><issn><json:string>1756-5383</json:string></issn><eissn><json:string>1756-5391</json:string></eissn><publisherId><json:string>JEBM</json:string></publisherId><volume>7</volume><issue>1</issue><pages><first>2</first><last>21</last><total>20</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>BRICS</value></json:item><json:item><value>Brics</value></json:item></subject></host><ark><json:string>ark:/67375/WNG-0BHX1WZW-H</json:string></ark><categories><wos></wos><scienceMetrix></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Health Policy</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - General Medicine</json:string></scopus><inist><json:string>1 - sciences humaines et sociales</json:string></inist></categories><publicationDate>2014</publicationDate><copyrightDate>2014</copyrightDate><doi><json:string>10.1111/jebm.12081</json:string></doi><id>4019A840609BB93ED0DBEA2B4A948A87ABABC78B</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-0BHX1WZW-H/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-0BHX1WZW-H/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-0BHX1WZW-H/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries</title><title level="a" type="short">Universal access to ART in BRICS countries</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-QW5Q88H5-V">Wiley Publishing Ltd</publisher><availability><licence>© 2013 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd</licence></availability><date type="published" when="2014-02"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries</title><title level="a" type="short">Universal access to ART in BRICS countries</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">Jing</forename><surname>Sun</surname></persName><affiliation><orgName type="division">National Institute of Hospital Administration</orgName><orgName type="division">National Health and Family Planning Commission (NHFPC)</orgName><orgName type="division">BRICS Medicines Alliance</orgName><orgName type="institution">Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group</orgName><address><country key="CN" xml:lang="en">CHINA</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Alexandra Crispim</forename><surname>Boing</surname></persName><affiliation><orgName type="division">Department of Public Health</orgName><orgName type="institution">Federal University of Santa Catarina</orgName><address><country key="BR" xml:lang="en">BRAZIL</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Marysabel PT</forename><surname>Silveira</surname></persName><affiliation><orgName type="division">Instituto de Biologia, Departamento de Fisiologia e Farmacologia</orgName><orgName type="institution">Universidade Federal de Pelotas</orgName><address><country key="BR" xml:lang="en">BRAZIL</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">Andréa D</forename><surname>Bertoldi</surname></persName><affiliation><orgName type="division">Programa de Pós‐graduação em Epidemiologia</orgName><orgName type="institution">Universidade Federal de Pelotas, Pelotas, RS</orgName><address><country key="BR" xml:lang="en">BRAZIL</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Liliya E</forename><surname>Ziganshina</surname></persName><affiliation><orgName type="division">Department of Basic and Clinical Pharmacology</orgName><orgName type="division">Kazan Federal University</orgName><orgName type="institution">BRICS Medicines Alliance</orgName><address><country key="RU" xml:lang="en">RUSSIAN FEDERATION</country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">Veronica N</forename><surname>Khaziakhmetova</surname></persName><affiliation><orgName type="division">Department of Basic and Clinical Pharmacology</orgName><orgName type="division">Kazan Federal University</orgName><orgName type="institution">BRICS Medicines Alliance</orgName><address><country key="RU" xml:lang="en">RUSSIAN FEDERATION</country></address></affiliation></author><author xml:id="author-0006"><persName><forename type="first">Rashida M</forename><surname>Khamidulina</surname></persName><affiliation><orgName type="division">Department of Basic and Clinical Pharmacology</orgName><orgName type="division">Kazan Federal University</orgName><orgName type="institution">BRICS Medicines Alliance</orgName><address><country key="RU" xml:lang="en">RUSSIAN FEDERATION</country></address></affiliation></author><author xml:id="author-0007"><persName><forename type="first">Maulik R</forename><surname>Chokshi</surname></persName><affiliation><orgName type="division">Public Health Foundation</orgName><orgName type="institution">BRICS Medicines Alliance</orgName><address><country key="IN" xml:lang="en">INDIA</country></address></affiliation></author><author xml:id="author-0008"><persName><forename type="first">Shelley</forename><surname>McGee</surname></persName><affiliation><orgName type="division">Healthcare Policy Analyst, Market Access</orgName><orgName type="institution">SANOFI, BRICS Medicines Alliance</orgName><address><country key="ZA" xml:lang="en">SOUTH AFRICA</country></address></affiliation></author><author xml:id="author-0009"><persName><forename type="first">Fatima</forename><surname>Suleman</surname></persName><affiliation><orgName type="division">Discipline of Pharmaceutical Sciences</orgName><orgName type="division">University of KwaZulu‐Natal</orgName><orgName type="institution">BRICS Medicines Alliance</orgName><address><country key="ZA" xml:lang="en">SOUTH AFRICA</country></address></affiliation></author><idno type="istex">4019A840609BB93ED0DBEA2B4A948A87ABABC78B</idno><idno type="ark">ark:/67375/WNG-0BHX1WZW-H</idno><idno type="DOI">10.1111/jebm.12081</idno><idno type="unit">JEBM12081</idno><idno type="toTypesetVersion">file:JEBM.JEBM12081.pdf</idno></analytic><monogr><title level="j" type="main">Journal of Evidence‐Based Medicine</title><title level="j" type="alt">JOURNAL OF EVIDENCE-BASED MEDICINE</title><idno type="pISSN">1756-5383</idno><idno type="eISSN">1756-5391</idno><idno type="book-DOI">10.1111/(ISSN)1756-5391</idno><idno type="book-part-DOI">10.1111/jebm.2014.7.issue-1</idno><idno type="product">JEBM</idno><imprint><biblScope unit="vol">7</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="2">2</biblScope><biblScope unit="page" to="21">21</biblScope><biblScope unit="page-count">20</biblScope><date type="published" when="2014-02"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract style="main"><head>Abstract</head><p>This article illustrates how the BRICS countries have been building their focused leadership, making important high level commitment and national policy changes, and improving their health systems, in addressing the HIV/AIDS epidemics in respective settings. Specific aspects are focused on efforts of creating public provisions to secure universal access to ARVs from the aspects of active responsive system and national program, health system strengthening, fostering local production of ARVs, supply chain management, and information system strengthening. Challenges in each BRICS country are analyzed respectively. The most important contributors to the success of response to HIV/AIDS include: creating legal basis for healthcare as a fundamental human right; political commitment to necessary funding for universal access and concrete actions to secure equal quality care; comprehensive system to secure demands that all people in need are capable of accessing prevention, treatment and care; active community involvement; decentralization of the management system considering the local settings; integration of treatment and prevention; taking horizontal approach to strengthen health systems; fully use of the TRIPS flexibility; and regular monitoring and evaluation to serve evidence based decision making.</p></abstract><textClass><keywords rend="articleCategory"><term>BRICS</term></keywords><keywords rend="tocHeading1"><term>Brics</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-0BHX1WZW-H/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en" xml:id="JEBM12081"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1756-5391</doi><issn type="print">1756-5383</issn><issn type="electronic">1756-5391</issn><idGroup><id type="product" value="JEBM"></id></idGroup><titleGroup><title type="main" sort="JOURNAL OF EVIDENCE-BASED MEDICINE">Journal of Evidence‐Based Medicine</title><title type="short">JOURNAL OF EVIDENCE‐BASED MEDICINE</title></titleGroup></publicationMeta><publicationMeta level="part" position="02101"><doi>10.1111/jebm.2014.7.issue-1</doi><copyright ownership="publisher">Copyright © 2014 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd</copyright><numberingGroup><numbering type="journalVolume" number="7">7</numbering><numbering type="journalIssue">1</numbering></numberingGroup><coverDate startDate="2014-02">February 2014</coverDate></publicationMeta><publicationMeta level="unit" position="30" type="article" status="forIssue"><doi origin="wiley">10.1111/jebm.12081</doi><idGroup><id type="unit" value="JEBM12081"></id></idGroup><countGroup><count type="pageTotal" number="20"></count></countGroup><titleGroup><title type="articleCategory">BRICS</title><title type="tocHeading1">Brics</title></titleGroup><copyright ownership="publisher">© 2013 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd</copyright><eventGroup><event type="manuscriptReceived" date="2013-10-29"></event><event type="manuscriptAccepted" date="2013-11-12"></event><event type="xmlCreated" agent="Aptara" date="2013-12-04"></event><event type="publishedOnlineAccepted" date="2013-11-26"></event><event type="firstOnline" date="2014-02-23"></event><event type="publishedOnlineFinalForm" date="2014-02-23"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-08"></event></eventGroup><numberingGroup><numbering type="pageFirst">2</numbering><numbering type="pageLast">21</numbering></numberingGroup><correspondenceTo><lineatedText><line><b>Correspondence</b></line><line>Jing Sun, National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance Country Leader; Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, 38 Xueyuan Road, Haidian District, Beijing 100191, China. Tel: +86‐10‐62026607; Fax: +86‐10‐82801614; <i>Email</i>: <email>sunjingx@yahoo.com</email></line></lineatedText></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:JEBM.JEBM12081.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries</title><title type="shortAuthors"><i>J. Sun</i> et al.</title><title type="short">Universal access to ART in BRICS countries</title></titleGroup><creators><creator xml:id="jebm12081-cr-0001" creatorRole="author" affiliationRef="#jebm12081-aff-0001" corresponding="yes"><personName><givenNames>Jing</givenNames><familyName>Sun</familyName></personName></creator><creator xml:id="jebm12081-cr-0002" creatorRole="author" affiliationRef="#jebm12081-aff-0002"><personName><givenNames>Alexandra Crispim</givenNames><familyName>Boing</familyName></personName></creator><creator xml:id="jebm12081-cr-0003" creatorRole="author" affiliationRef="#jebm12081-aff-0003"><personName><givenNames>Marysabel PT</givenNames><familyName>Silveira</familyName></personName></creator><creator xml:id="jebm12081-cr-0004" creatorRole="author" affiliationRef="#jebm12081-aff-0004"><personName><givenNames>Andréa D</givenNames><familyName>Bertoldi</familyName></personName></creator><creator xml:id="jebm12081-cr-0005" creatorRole="author" affiliationRef="#jebm12081-aff-0005"><personName><givenNames>Liliya E</givenNames><familyName>Ziganshina</familyName></personName></creator><creator xml:id="jebm12081-cr-0006" creatorRole="author" affiliationRef="#jebm12081-aff-0005"><personName><givenNames>Veronica N</givenNames><familyName>Khaziakhmetova</familyName></personName></creator><creator xml:id="jebm12081-cr-0007" creatorRole="author" affiliationRef="#jebm12081-aff-0005"><personName><givenNames>Rashida M</givenNames><familyName>Khamidulina</familyName></personName></creator><creator xml:id="jebm12081-cr-0008" creatorRole="author" affiliationRef="#jebm12081-aff-0006"><personName><givenNames>Maulik R</givenNames><familyName>Chokshi</familyName></personName></creator><creator xml:id="jebm12081-cr-0009" creatorRole="author" affiliationRef="#jebm12081-aff-0007"><personName><givenNames>Shelley</givenNames><familyName>McGee</familyName></personName></creator><creator xml:id="jebm12081-cr-0010" creatorRole="author" affiliationRef="#jebm12081-aff-0008"><personName><givenNames>Fatima</givenNames><familyName>Suleman</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="jebm12081-aff-0001" countryCode="CN"><orgDiv>National Institute of Hospital Administration</orgDiv><orgDiv>National Health and Family Planning Commission (NHFPC)</orgDiv><orgDiv>BRICS Medicines Alliance</orgDiv><orgName>Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group</orgName><address><country>China</country></address></affiliation><affiliation xml:id="jebm12081-aff-0002" countryCode="BR"><orgDiv>Department of Public Health</orgDiv><orgName>Federal University of Santa Catarina</orgName><address><country>Brazil</country></address></affiliation><affiliation xml:id="jebm12081-aff-0003" countryCode="BR"><orgDiv>Instituto de Biologia, Departamento de Fisiologia e Farmacologia</orgDiv><orgName>Universidade Federal de Pelotas</orgName><address><country>Brazil</country></address></affiliation><affiliation xml:id="jebm12081-aff-0004" countryCode="BR"><orgDiv>Programa de Pós‐graduação em Epidemiologia</orgDiv><orgName>Universidade Federal de Pelotas, Pelotas, RS</orgName><address><country>Brazil</country></address></affiliation><affiliation xml:id="jebm12081-aff-0005" countryCode="RU"><orgDiv>Department of Basic and Clinical Pharmacology</orgDiv><orgDiv>Kazan Federal University</orgDiv><orgName>BRICS Medicines Alliance</orgName><address><country>Russian Federation</country></address></affiliation><affiliation xml:id="jebm12081-aff-0006" countryCode="IN"><orgDiv>Public Health Foundation</orgDiv><orgName>BRICS Medicines Alliance</orgName><address><country>India</country></address></affiliation><affiliation xml:id="jebm12081-aff-0007" countryCode="ZA"><orgDiv>Healthcare Policy Analyst, Market Access</orgDiv><orgName>SANOFI, BRICS Medicines Alliance</orgName><address><country>South Africa</country></address></affiliation><affiliation xml:id="jebm12081-aff-0008" countryCode="ZA"><orgDiv>Discipline of Pharmaceutical Sciences</orgDiv><orgDiv>University of KwaZulu‐Natal</orgDiv><orgName>BRICS Medicines Alliance</orgName><address><country>South Africa</country></address></affiliation></affiliationGroup><abstractGroup><abstract type="main"><title type="main">Abstract</title><p>This article illustrates how the BRICS countries have been building their focused leadership, making important high level commitment and national policy changes, and improving their health systems, in addressing the HIV/AIDS epidemics in respective settings. Specific aspects are focused on efforts of creating public provisions to secure universal access to ARVs from the aspects of active responsive system and national program, health system strengthening, fostering local production of ARVs, supply chain management, and information system strengthening. Challenges in each BRICS country are analyzed respectively. The most important contributors to the success of response to HIV/AIDS include: creating legal basis for healthcare as a fundamental human right; political commitment to necessary funding for universal access and concrete actions to secure equal quality care; comprehensive system to secure demands that all people in need are capable of accessing prevention, treatment and care; active community involvement; decentralization of the management system considering the local settings; integration of treatment and prevention; taking horizontal approach to strengthen health systems; fully use of the TRIPS flexibility; and regular monitoring and evaluation to serve evidence based decision making.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Universal access to ART in BRICS countries</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries</title></titleInfo><name type="personal"><namePart type="given">Jing</namePart><namePart type="family">Sun</namePart><affiliation>National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance, Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, China</affiliation><affiliation>Jing Sun, National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance Country Leader; Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, 38 Xueyuan Road, Haidian District, Beijing 100191, China. Tel: +86‐10‐62026607; Fax: +86‐10‐82801614; :</affiliation><affiliation>E-mail: sunjingx@yahoo.com</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Alexandra Crispim</namePart><namePart type="family">Boing</namePart><affiliation>Department of Public Health, Federal University of Santa Catarina, Brazil</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Marysabel PT</namePart><namePart type="family">Silveira</namePart><affiliation>Instituto de Biologia, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pelotas, Brazil</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Andréa D</namePart><namePart type="family">Bertoldi</namePart><affiliation>Programa de Pós‐graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, RS, Brazil</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Liliya E</namePart><namePart type="family">Ziganshina</namePart><affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Veronica N</namePart><namePart type="family">Khaziakhmetova</namePart><affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Rashida M</namePart><namePart type="family">Khamidulina</namePart><affiliation>Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Maulik R</namePart><namePart type="family">Chokshi</namePart><affiliation>Public Health Foundation, BRICS Medicines Alliance, India</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Shelley</namePart><namePart type="family">McGee</namePart><affiliation>Healthcare Policy Analyst, Market Access, SANOFI, BRICS Medicines Alliance, South Africa</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Fatima</namePart><namePart type="family">Suleman</namePart><affiliation>Discipline of Pharmaceutical Sciences, University of KwaZulu‐Natal, BRICS Medicines Alliance, South Africa</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2014-02</dateIssued><dateCreated encoding="w3cdtf">2013-12-04</dateCreated><dateCaptured encoding="w3cdtf">2013-10-29</dateCaptured><dateValid encoding="w3cdtf">2013-11-12</dateValid><copyrightDate encoding="w3cdtf">2014</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract>This article illustrates how the BRICS countries have been building their focused leadership, making important high level commitment and national policy changes, and improving their health systems, in addressing the HIV/AIDS epidemics in respective settings. Specific aspects are focused on efforts of creating public provisions to secure universal access to ARVs from the aspects of active responsive system and national program, health system strengthening, fostering local production of ARVs, supply chain management, and information system strengthening. Challenges in each BRICS country are analyzed respectively. The most important contributors to the success of response to HIV/AIDS include: creating legal basis for healthcare as a fundamental human right; political commitment to necessary funding for universal access and concrete actions to secure equal quality care; comprehensive system to secure demands that all people in need are capable of accessing prevention, treatment and care; active community involvement; decentralization of the management system considering the local settings; integration of treatment and prevention; taking horizontal approach to strengthen health systems; fully use of the TRIPS flexibility; and regular monitoring and evaluation to serve evidence based decision making.</abstract><relatedItem type="host"><titleInfo><title>Journal of Evidence‐Based Medicine</title></titleInfo><titleInfo type="abbreviated"><title>JOURNAL OF EVIDENCE‐BASED MEDICINE</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>BRICS</topic><topic>Brics</topic></subject><identifier type="ISSN">1756-5383</identifier><identifier type="eISSN">1756-5391</identifier><identifier type="DOI">10.1111/(ISSN)1756-5391</identifier><identifier type="PublisherID">JEBM</identifier><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>2</start><end>21</end><total>20</total></extent></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0001"><titleInfo><title>Countries offering free access to HIV treatment</title></titleInfo><name type="corporate"><namePart>WHO</namePart></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0002"><titleInfo><title>Global Report: UNAIDS Report on the Global AIDS Epidemic 2012</title></titleInfo><name type="corporate"><namePart>UNAIDS</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0003"><titleInfo><title>Political Declaration on HIV/AIDS: Intensifying our Efforts to Eliminate HIV/AIDS 2011</title></titleInfo><name type="corporate"><namePart>United Nations</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0004"><titleInfo><title>Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users</title></titleInfo><name type="corporate"><namePart>WHO, UNODC, UNAIDS</namePart></name><genre>other</genre><part><date>2009</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0005"><titleInfo><title>BRICS Ministers of Health call for renewed efforts to face HIV and global health challenges</title></titleInfo><name type="corporate"><namePart>UNAIDS</namePart></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0006"><titleInfo><title>Brazil and access to AIDS medication: public health as a human right issue</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Galvão</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book-chapter</genre><relatedItem type="host"><titleInfo><title>Human Rights in Brazil</title></titleInfo><originInfo><publisher>Social Network for Justice and Human Rights and Global Exchange</publisher><place><placeTerm type="text">São Paulo</placeTerm></place></originInfo><part><date>2002</date><extent unit="pages"><start>181</start><end>88</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0007"><titleInfo><title>Access to antiretrovirals: where South Africa, China, and Brazil meet</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Galvão</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Galvão J. Access to antiretrovirals: where South Africa, China, and Brazil meet. Lancet 2004;363: 493.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>363</number></detail><extent unit="pages"><start>493</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>363</number></detail><extent unit="pages"><start>493</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0008"><titleInfo><title>Lei n° 9.313 de 13 de Novembro de 1996</title></titleInfo><name type="corporate"><namePart>Brasil</namePart></name><genre>other</genre><part><date>1996</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0009"><titleInfo><title>Russia strengthens commitment to reversing the AIDS epidemic in the region</title></titleInfo><name type="corporate"><namePart>UNAIDS</namePart></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0010"><titleInfo><title>AIDS: a serious challenge to public health</title></titleInfo><name type="personal"><namePart type="given">TK.</namePart><namePart type="family">Ghosh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ghosh TK. AIDS: a serious challenge to public health. Journal of the Indian Medical Association 1986;84(1): 29–30.</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>29</start><end>30</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of the Indian Medical Association</title></titleInfo><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>29</start><end>30</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0011"><titleInfo><title>Reporting system of the statutory communicable diseases</title></titleInfo><name type="corporate"><namePart>China Center for Disease Control and Prevention</namePart></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0012"><titleInfo><title>A History of Official Government HIV/AIDS Policy in South Africa</title></titleInfo><name type="corporate"><namePart>South African History Online</namePart></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0013"><titleInfo><title>Global Report: UNAIDS report on the global AIDS epidemic 2012</title></titleInfo><name type="corporate"><namePart>UNAIDS</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0014"><titleInfo><title>Progress Report on the Brazilian Response to HIV/AIDS (2010–2011)</title></titleInfo><name type="corporate"><namePart>Brazilian Ministry of Health, Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis</namePart></name><genre>other</genre><part><date>2012</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0015"><titleInfo><title>The changing face of aid in Russia, Fiona Clarck's report</title></titleInfo><name type="corporate"><namePart>The Lancet</namePart></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0016"><titleInfo><title>National AIDS Control Organization. Available at http://naco.gov.in/NACO/Quick_Links/Publication/Annual_Report/NACO_Annual_Report/Annual_Report_2012‐‐13/ (accessed 7 November 2013).</title></titleInfo><name type="corporate"><namePart>National AIDS Control Organization</namePart></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0017"><titleInfo><title>China AIDS Response Progress Report</title></titleInfo><name type="corporate"><namePart>Ministry of Health, People's Republic of China</namePart></name><genre>other</genre><part><date>2012</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0018"><titleInfo><title>Joint United Nations Program on HIV/AIDS. Estimates for the HIV/AIDS Epidemic in China</title></titleInfo><name type="corporate"><namePart>Ministry of Health, People's Republic of China and World Health Organization</namePart></name><genre>other</genre><part><date>2011</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0019"><titleInfo><title>National Strategic Plan 2012–2016</title></titleInfo><name type="corporate"><namePart>South Africa National AIDS Council</namePart></name><genre>journal-article</genre><note type="citation/reference">South Africa National AIDS Council. National Strategic Plan 2012–2016. SANAC. 2011.</note><part><date>2011</date></part><relatedItem type="host"><titleInfo><title>SANAC.</title></titleInfo><part><date>2011</date></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0020"><titleInfo><title>Global AIDS Response Progress Report 2012</title></titleInfo><name type="corporate"><namePart>Republic of South Africa</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0021"><titleInfo><title>Universal Access in South Africa. Available at http://www.avert.org/universal‐access‐to‐treatment‐in‐south‐africa.htm (accessed 16 September 2013).</title></titleInfo><name type="corporate"><namePart>Universal Access in South Africa</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0022"><titleInfo><title>The Brazilian experience in providing universal access to antiretroviral therapy</title></titleInfo><name type="personal"><namePart type="given">PR</namePart><namePart type="family">Teixeira</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MAA</namePart><namePart type="family">Vitória</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Barcarolo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book-chapter</genre><relatedItem type="host"><titleInfo><title>Economics of AIDS and Access to HIV/AIDS Care in Developing Countries, Issues and Challenges</title></titleInfo><originInfo><publisher>AgenceNationale de Recherchessur le Sida</publisher><place><placeTerm type="text">Paris, France</placeTerm></place></originInfo><part><date>2003</date><extent unit="pages"><start>69</start><end>88</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0023"><titleInfo><title>Galvão J. AIDS no Brasil. São Paulo, Brazil: Editora, 2000: 34.</title></titleInfo><note type="citation/reference">Galvão J. AIDS no Brasil. São Paulo, Brazil: Editora, 2000: 34.</note><name type="personal"><namePart type="given">J</namePart><namePart type="family">Galvão</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Editora</publisher><place><placeTerm type="text">São Paulo, Brazil</placeTerm></place></originInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>34</number></detail></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0024"><titleInfo><title>Pinheiro R, Araújo de Mattos R. OsSentidos da Integralidade: Na Atenção e no CuidadoàSaúde. Rio de Janeiro, Brazil: UERJ, 2001.</title></titleInfo><note type="citation/reference">Pinheiro R, Araújo de Mattos R. OsSentidos da Integralidade: Na Atenção e no CuidadoàSaúde. Rio de Janeiro, Brazil: UERJ, 2001.</note><name type="personal"><namePart type="given">R</namePart><namePart type="family">Pinheiro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Araújo de Mattos</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>UERJ</publisher><place><placeTerm type="text">Rio de Janeiro, Brazil</placeTerm></place></originInfo><part><date>2001</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0025"><titleInfo><title>Access to antiretroviral treatment in Brazil</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Hallal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Ravasi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Kuchenbecker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Greco</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Simão</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hallal R, Ravasi G, Kuchenbecker R, Greco D, Simão M. Access to antiretroviral treatment in Brazil. Revista Tempus ActasemSaúdeColetiva.Brasilia,NESP 2010;2(2): 53–65.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>53</start><end>65</end></extent></part><relatedItem type="host"><titleInfo><title>Revista Tempus ActasemSaúdeColetiva.Brasilia,NESP</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>53</start><end>65</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0026"><titleInfo><title>Brazilian activists win AIDS‐treatment battle</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Foreman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre><part><date>1996</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0027"><titleInfo><title>Portaria nº 2.313 de 19 de Dezembro de 2002</title></titleInfo><name type="corporate"><namePart>Brasil</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0028"><titleInfo><title>Antiretroviral drugs for all? Obstacles in accessing treatment Lessons from India</title></titleInfo><name type="corporate"><namePart>Panos India</namePart></name><genre>other</genre><part><date>2007</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0029"><titleInfo><title>Results: World AIDS Day Report 2012</title></titleInfo><name type="corporate"><namePart>UNAIDS</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0030"><titleInfo><title>Together We Will End AIDS</title></titleInfo><name type="corporate"><namePart>UNAIDS</namePart></name><genre>other</genre><part><date>2012</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0031"><titleInfo><title>DiárioOficial da RepúblicaFederativa do Brasil</title></titleInfo><name type="corporate"><namePart>Brasil Lei n°. 8.080</namePart></name><genre>other</genre><part><date>1990</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0032"><titleInfo><title>Russian Federation‐Health system review</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Popovich</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Potapchik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Shishkin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Richardson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Vacroux</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Mathivet</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Popovich L, Potapchik E, Shishkin S, Richardson E, Vacroux A, Mathivet B. Russian Federation‐Health system review. European Observatory on Health Systems and Politics Health Systems in Transition 2011;13(7): 1–190.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>1</start><end>190</end></extent></part><relatedItem type="host"><titleInfo><title>European Observatory on Health Systems and Politics Health Systems in Transition</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>1</start><end>190</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0033"><titleInfo><title>Building BRICs: pharma's key emerging markets are becoming giants</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Chris</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0034"><titleInfo><title>World Health Organization SARO. India: National Health System Profile. New Delhi: World Health Organization, South‐East Asia Regional Office, 2007.</title></titleInfo><name type="corporate"><namePart>World Health Organization SARO</namePart></name><note type="citation/reference">World Health Organization SARO. India: National Health System Profile. New Delhi: World Health Organization, South‐East Asia Regional Office, 2007.</note><genre>book</genre><originInfo><publisher>World Health Organization, South‐East Asia Regional Office</publisher><place><placeTerm type="text">New Delhi</placeTerm></place></originInfo><part><date>2007</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0035"><titleInfo><title>National Health Accounts India 2004–5</title></titleInfo><name type="corporate"><namePart>National Health Accounts Cell, Ministry of Health and Family Welfare, Government of India in collaboration with WHO Country Office for India</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0036"><titleInfo><title>Health care in South Africa</title></titleInfo><name type="corporate"><namePart>Southafrica.info</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0037"><titleInfo><title>TRIPS post‐2005 and access to new antiretroviral treatments in southern countries: issues and challenges</title></titleInfo><name type="personal"><namePart type="given">F</namePart><namePart type="family">Orsi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">D'Almeida</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Hasenclever</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Camara</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Tigre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Coriat</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Orsi F, D'Almeida C, Hasenclever L, Camara M, Tigre P, Coriat B. TRIPS post‐2005 and access to new antiretroviral treatments in southern countries: issues and challenges. AIDS 2007;21(15): 1997–2003.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><detail type="issue"><caption>no.</caption><number>15</number></detail><extent unit="pages"><start>1997</start><end>2003</end></extent></part><relatedItem type="host"><titleInfo><title>AIDS</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><detail type="issue"><caption>no.</caption><number>15</number></detail><extent unit="pages"><start>1997</start><end>2003</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0038"><titleInfo><title>Cepaluni, Gabriel and TulloVigevani. Brazilian Foreign Policy in Changing Times: The Quest for Autonomy from Sarney to Lula. New York: Lexington Books, 2009.</title></titleInfo><name type="corporate"><namePart>Cepaluni, Gabriel and TulloVigevani</namePart></name><note type="citation/reference">Cepaluni, Gabriel and TulloVigevani. Brazilian Foreign Policy in Changing Times: The Quest for Autonomy from Sarney to Lula. New York: Lexington Books, 2009.</note><genre>book</genre><originInfo><publisher>Lexington Books</publisher><place><placeTerm type="text">New York</placeTerm></place></originInfo><part><date>2009</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0039"><titleInfo><title>Building BRICs: pharma's key emerging markets are becoming giants</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Chris</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0040"><titleInfo><title>Departamento de DST, AIDS e HepatitesVirais</title></titleInfo><name type="corporate"><namePart>BrasilMinistério da Saúde</namePart></name><genre>other</genre><part><date>2013</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0041"><titleInfo><title>AgênciaNacional de VigilânciaSanitária</title></titleInfo><name type="corporate"><namePart>BrasilMinistério da Saúde</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0042"><titleInfo><title>Portaria nº 104, de 25 de Janeiro de 2011</title></titleInfo><name type="corporate"><namePart>BrasilMinistério da Saúde</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0043"><titleInfo><title>Evaluation of Health Management Information System in India Need for Computerized Databases in HMIS</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Bodavala</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre><part><date>1998</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0044"><titleInfo><title>Acessogratuitoaosmedicamentosantirretrovirais (manuscrito): contribuição do Legislativopara a políticabrasileira de combateà Aids/Maria Gabriela da Silva Lopes e CarravillaAzevedo</title></titleInfo><name type="personal"><namePart type="given">MGSLC</namePart><namePart type="family">Azevedo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre><part><date>2010</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0045"><titleInfo><title>Drugs, health policy and AIDS: changes in a dependent policy</title></titleInfo><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Loyola</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Loyola MA. Drugs, health policy and AIDS: changes in a dependent policy. Ciência&SaúdeColetiva 2008;13(Sup): 763–78.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>763</start><end>78</end></extent></part><relatedItem type="host"><titleInfo><title>Ciência&SaúdeColetiva</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>763</start><end>78</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0046"><titleInfo><title>Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment</title></titleInfo><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Nunn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EM</namePart><namePart type="family">Fonseca</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FI</namePart><namePart type="family">Bastos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Gruskin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Salomon</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. PLoS Medicine 2007;4(11): e305. doi:10.1371/journal.pmed.0040305.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><detail type="issue"><caption>no.</caption><number>11</number></detail><extent unit="pages"><start>e305</start></extent></part><relatedItem type="host"><titleInfo><title>PLoS Medicine</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><detail type="issue"><caption>no.</caption><number>11</number></detail><extent unit="pages"><start>e305</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0047"><titleInfo><title>Sustainability of Brazilian policy for access to antiretroviral drugs</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Grangeiro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Teixeira</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FI</namePart><namePart type="family">Bastos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Teixeira</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Grangeiro A, Teixeira L, Bastos FI, Teixeira P. Sustainability of Brazilian policy for access to antiretroviral drugs. Rev SaúdePública 2006;40(Supl): 60–9.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>60</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Rev SaúdePública</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>60</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0048"><titleInfo><title>Public production of anti‐retroviral medicines in Brazil, 1990–2007</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Flynn</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Flynn M. Public production of anti‐retroviral medicines in Brazil, 1990–2007. Development and Change 2008;39(4): 513–36.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>513</start><end>36</end></extent></part><relatedItem type="host"><titleInfo><title>Development and Change</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>513</start><end>36</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0049"><titleInfo><title>The role of governmental policies in nurturing the pharmaceutical industry in Brazil: the mix of centralized procurement, public drug productions and public‐private partnerships</title></titleInfo><name type="personal"><namePart type="given">WF</namePart><namePart type="family">Sorte Jr</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sorte Jr WF. The role of governmental policies in nurturing the pharmaceutical industry in Brazil: the mix of centralized procurement, public drug productions and public‐private partnerships. Forum of International Studies 41(March 2012).</note><part><detail type="volume"><caption>vol.</caption><number>41</number></detail></part><relatedItem type="host"><titleInfo><title>Forum of International Studies</title></titleInfo><part><detail type="volume"><caption>vol.</caption><number>41</number></detail></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0050"><titleInfo><title>Rights here, right now!– the reality of injecting drug users in Russia</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Aasland</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0051"><titleInfo><title>Too little, too late as China's Aids death rate explodes</title></titleInfo><name type="corporate"><namePart>The Independent</namePart></name><genre>other</genre><part><date>2009</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0052"><titleInfo><title>TB/HIV integration: lessons learned from implementation of a TB/HIV “one stop shop” at primary health care clinics in rural Lesotho</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Bygrave</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Trivino</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Makakole</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre><part><date>2010</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0053"><titleInfo><title>Médecins Sans Frontières, Western Cape Province Department of Health, City of Cape Town Department of Health, University of Cape Town, Center for Infectious Disease Epidemiology and Research</title></titleInfo><genre>other</genre><part><date>2011</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0054"><titleInfo><title>Speed up scale‐up: strategies, tools and policies to get the best HIV treatment to more people, sooner</title></titleInfo><name type="corporate"><namePart>UNAIDS, Médecins Sans Frontières</namePart></name><genre>other</genre><part><date>2012</date></part></relatedItem><relatedItem type="references" displayLabel="jebm12081-cit-0055"><titleInfo><title>The role of governmental policies in nurturing the pharmaceutical industry in Brazil: the mix of centralized procurement, public drug productions and public‐private partnerships</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Junior</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Francisco</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Junior S, Francisco W. The role of governmental policies in nurturing the pharmaceutical industry in Brazil: the mix of centralized procurement, public drug productions and public‐private partnerships. Forum of International Studies 41(March 2012).</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>41</number></detail></part><relatedItem type="host"><titleInfo><title>Forum of International Studies</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>41</number></detail></part></relatedItem></relatedItem><identifier type="istex">4019A840609BB93ED0DBEA2B4A948A87ABABC78B</identifier><identifier type="ark">ark:/67375/WNG-0BHX1WZW-H</identifier><identifier type="DOI">10.1111/jebm.12081</identifier><identifier type="ArticleID">JEBM12081</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2014 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd© 2013 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-15</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-0BHX1WZW-H/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002007 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002007 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:4019A840609BB93ED0DBEA2B4A948A87ABABC78B
|texte= Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries
}}
| This area was generated with Dilib version V0.6.33. |  |